Want to see AU:ENP full AI Analyst Report?
Tryptamine Therapeutics (ENP) Income Statement
Tryptamine Therapeutics Income Statement
Last quarter (Q4 2025), Tryptamine Therapeutics's total revenue was $0.00. In Q4, Tryptamine Therapeutics's net income was $-1.44M. See Tryptamine Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Aug 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 618.57K | $ 99.73K | |
| $ -27.34K | $ -54.34K | $ -6.77K | $ 618.57K | $ 99.73K | |
| $ 6.74M | $ 6.68M | $ 4.96M | $ 10.21M | $ 14.21M | |
| Depreciation and Amortization | $ 27.34K | $ 54.34K | $ 6.77K | $ 1.70M | $ 1.73M |
| $ -6.74M | $ -5.27M | $ -6.70M | $ -5.10M | $ -8.27M | |
| $ -6.77M | $ -6.73M | $ -4.97M | $ -9.59M | $ -14.11M | |
| $ -8.17K | $ -184.29K | $ -2.28M | $ 2.46M | $ 4.03M | |
| $ -6.78M | $ -6.91M | $ -7.25M | $ -7.13M | $ -10.08M | |
| $ -4.87M | $ -5.33M | $ -6.14M | $ -7.13M | $ -10.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.09 | $ -0.14 |
| Diluted EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.09 | $ -0.14 |
| Weighted Average Shares Outstanding | 1.57B | 1.38B | 506.71M | 78.76M | 71.08M |
| Weighted Average Shares Outstanding (Diluted) | 1.57B | 1.38B | 506.71M | 78.76M | 71.08M |
Currency in AUD
